Skip to Main Content

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients



Phase III

What is the purpose of this trial?

Brief Summary:

The purpose of this study is to determine whether the BMS Attachment Inhibitor (BMS-663068) is effective in the treatment of heavily treatment experienced HIV-1 patients with multi-drug resistance.

  • Trial with
    ViiV Healthcare Company
  • Start Date
  • End Date
Trial Image

For more information about this study, contact:

Laurie Andrews

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC